C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2004
12/29/2004	WO2003082370A3 Transcellular drug delivery system
12/29/2004	WO2003068983A9 Use of the axl receptor for diagnosis and treatment of renal disease
12/29/2004	WO2003060162A8 Method of specifying snp
12/29/2004	WO2003057178A3 Viral capsid assembly intermediates
12/29/2004	WO2003057146A3 Novel compositions and methods for cancer
12/29/2004	WO2002089747A3 Compositions and methods for the therapy and diagnosis of prostate cancer
12/29/2004	WO2000061774A3 Bone morphogenic proteins
12/29/2004	EP1491890A1 Method of evaluating hair growth-promoting activity
12/29/2004	EP1491889A2 Methods for aiding in the diagnosis of Alzheimer's disease by measuring amyloid-beta peptide (x = 41) and tau
12/29/2004	EP1491888A1 Gel having biosubstance fixed thereto and microarray utilizing the gel
12/29/2004	EP1491638A2 Apparatus and method for nucleic acid spatial ordering
12/29/2004	EP1491637A1 Process for improving efficiency of DNA amplification reactions
12/29/2004	EP1491634A1 Feedback resistant acetohydroxy acid synthetase mutants
12/29/2004	EP1491633A1 Novel carbonyl reductase, gene encoding it and process for producing optically active alcohols using the same
12/29/2004	EP1491632A2 Anti-alphavbeta3 humanized monoclonal antibodies
12/29/2004	EP1491631A1 Method of screening transporter inhibitor
12/29/2004	EP1491630A1 Novel n-acetylglucosamine transferase, nucleic acid encoding the same and use thereof in diagnosing cancer and/or tumor
12/29/2004	EP1491629A1 Novel method of highly sensitive nucleic acid analysis
12/29/2004	EP1491628A1 Novel galactose transferases, peptides thereof and nucleic acid encoding the same
12/29/2004	EP1491626A1 Method of assaying target nucleic acid and kit therefor
12/29/2004	EP1491625A1 Mutated isopropylmalate isomerase
12/29/2004	EP1491556A1 Humanized immunoglobulins and their production and use
12/29/2004	EP1491555A1 Anti-human hepatoma monoclonal antibody hab18 light/heavy chain variable region gene, and use thereof
12/29/2004	EP1491553A1 Peptides for the treatment of cancer associated with the human papilloma virus (hpv) and other epithelial tumours
12/29/2004	EP1491534A1 Novel hairpin polyamide
12/29/2004	EP1491216A1 Drugs comprising protein forming hollow nanoparticles and therapeutic substance to be transferred into cells fused therewith
12/29/2004	EP1491215A1 Remedies with the use of hollow protein nanoparticles presenting growth factor or the like
12/29/2004	EP1491210A1 Therapeutic drug using antibody-presenting hollow protein nanoparticles and hollow protein nanoparticles
12/29/2004	EP1491093A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/29/2004	EP1490768A1 Adaptive behavioral intrusion detection systems and methods
12/29/2004	EP1490696A2 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor (ghs)
12/29/2004	EP1490691A2 Luminescent, spheroid, non-autofluorescent silica gel particles having variable emission intensities and frequencies
12/29/2004	EP1490690A2 Novel compositions and methods in cancer associated with altered expression of mcm3ap
12/29/2004	EP1490689A1 Novel compositions and methods in cancer associated with altered expression of prlr
12/29/2004	EP1490688A1 Novel compositions and methods in cancer associated with altered expression of prdm 11
12/29/2004	EP1490686A2 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
12/29/2004	EP1490682A1 Detection of dna-binding proteins
12/29/2004	EP1490677A2 Computational method for designing enzymes for incorporation of amino acid analogs into proteins
12/29/2004	EP1490519A2 Life sciences business systems and methods
12/29/2004	EP1490514A2 Single primer isothermal nucleic acid amplification-enhanced analyte detection and quantification
12/29/2004	EP1490512A2 Artificial genes for use as controls in gene expression analysis systems
12/29/2004	EP1490511A2 Methods and systems for dynamic gene expression profiling
12/29/2004	EP1490509A2 Modulating insulin receptor signaling
12/29/2004	EP1490507A1 Method for the identification of microorganisms by means of in situ hybridization and flow cytometry
12/29/2004	EP1490500A1 Novel compositions and methods in cancer associated with altered expression of tbx21
12/29/2004	EP1490498A1 Saccharomyces cerevisiae mutant
12/29/2004	EP1490497A2 Egvi endoglucanase and nucleic acids encoding the same
12/29/2004	EP1490496A2 Early inflorescence-preferred regulatory elements and uses thereof
12/29/2004	EP1490494A1 Method of designing synthetic nucleic acid sequences for optimal protein expression in a host cell
12/29/2004	EP1490493A1 Enhancer sequence of the 5-aminolevulinic acid synthase gene
12/29/2004	EP1490492A2 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor
12/29/2004	EP1490491A2 Use of the protein maba (fabg1) of i mycobacterium tuberculosis /i for designing and screening antibiotics
12/29/2004	EP1490490A2 Antisense iap nucleobase oligomers and uses thereof
12/29/2004	EP1490489A1 Methods and means for monitoring and modulating gene silencing
12/29/2004	EP1490488A2 Purification methods for oligonucleotides and their analogs
12/29/2004	EP1490487A1 A method for selecting cell lines to be used for nuclear transfer in mammalian species
12/29/2004	EP1490486A2 Method of identifying genes controlling diferentiation
12/29/2004	EP1490484A2 Further bmp-2 inducible kinases and the uses thereof
12/29/2004	EP1490483A2 In vivo incorporation of unnatural amino acids
12/29/2004	EP1490482A1 Host cells having improved cell survival properties and methods to generate such cells
12/29/2004	EP1490481A2 Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media
12/29/2004	EP1490473A1 Bacterial spores
12/29/2004	EP1490406A1 Costimulatory molecule and its use
12/29/2004	EP1490405A2 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF
12/29/2004	EP1490400A2 Tenascin-w compositions and uses thereof
12/29/2004	EP1490395A1 Mutants of the p4 protein of nontypable haemophilus influenzae with reduced enzymatic activity
12/29/2004	EP1490389A2 Hepatitis c virus sub-genomic replicons
12/29/2004	EP1490388A1 Novel compositions and methods in cancer associated with altered expression of kcnj9
12/29/2004	EP1490387A2 A human ribonucleotide reductase m2 subunit
12/29/2004	EP1490386A2 Novel polypeptides and nucleic acids encoding the same
12/29/2004	EP1490385A2 Jagged 2 inhibitors for inducing apoptosis
12/29/2004	EP1490384A2 A building block forming a c-c bond upon reaction
12/29/2004	EP1490381A1 Human gene critical to fertility
12/29/2004	EP1490113A2 Raav vector compositions and methods for the treatment of choroidal neovascularization
12/29/2004	EP1490112A1 Method and agent for producing therapeutically active blood compositions
12/29/2004	EP1490110A2 Anti-alpha v beta 6 antibodies
12/29/2004	EP1490109A2 Egfr ligands and methods of use
12/29/2004	EP1490105A2 Multiple and multivalent dna vaccines in ovo
12/29/2004	EP1490101A1 Methods of enhancing immune induction involving mda-7
12/29/2004	EP1490099A2 Human monoclonal antibodies to influenza m2 protein and methods of making and using same
12/29/2004	EP1490085A2 Fc receptor homolog, reagents, and uses thereof
12/29/2004	EP1490082A2 Compositions and methods for preventing and treating cancer via modulating ube1l, isg15 and/or ubp43
12/29/2004	EP1490074A2 Mixed- cell gene therapy
12/29/2004	EP1490023A2 Drug signatures
12/29/2004	EP1490013A2 Methods, compositions, and kits for enhancing oligonucleotide-mediated nucleic acid sequence alteration using compositions comprising a histone deacetylase inhibitor, lambda phage beta protein, or hydroxyurea
12/29/2004	EP1489915A1 Treatment and prevention of inflammatory disorders
12/29/2004	EP1420629A4 Wheat plants having increased resistance to imidazolinone herbicides
12/29/2004	EP1409667B1 Process for preparing variant polynucleotides
12/29/2004	EP1408736A4 Plants characterized by enhanced growth and methods and nucleic acid constructs useful for generating same
12/29/2004	EP1390489A4 Phagemid vectors
12/29/2004	EP1379537A4 Pcr-hybridization assays specific for integrated retroviruses
12/29/2004	EP1379140A4 Production of pancreatic islet cells and delivery of insulin
12/29/2004	EP1373528A4 Novel expression vectors
12/29/2004	EP1349444A4 Monocotyledonous plant transformation
12/29/2004	EP1343516A4 Analogues of thiocoraline and be-22179
12/29/2004	EP1304916A4 Modification of plant resistance to diseases and/or pests
12/29/2004	EP1294929A4 Method to detect modulators of vegf kinase domain
12/29/2004	EP1255821B1 Protein c derivatives
12/29/2004	EP1222312B1 Multiplex pcr for detecting ehec infections
12/29/2004	EP1212449A4 Method for amplifying signal-flanking sequences from unknown genomic dna

1 ... 2108 2109 2110 2111 2112 2113 2114 2115 2116 2117 2118 2119 2120 2121 2122 2123 2124 2125 2126 2127 2128 ... 4023